http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2372910-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213d4d617889b8c30a9e4a073d237b81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
filingDate 2008-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1deef2ae3f3a5af569803e782289e9d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a0dc820370ba52922ee6de73067b7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75db6d0668d651aa39cda0c6d334ef1
publicationDate 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2372910-C1
titleOfInvention Method for microcyst prevention in patients with cystic tuberculosis
abstract FIELD: medicine. n SUBSTANCE: invention concerns medicine, particularly phthisiourology and covers prevention of development of microcystitis in patients suffering from cystic tuberculosis. It is ensured by introduction of isoniasid by indirect lymphotropic technique through forming a local lymphostasis. Rifampicin is introduced in microclyster as a component of the medicinal cocktail containing Novocaine 0.5% 50 ml + Rifampicin 0.6 g + dimexid 5 ml. In addition, spasmex is prescribed in a dose 15 mg twice a day within 3 months. n EFFECT: providing good tolerance, the method enables stable relief of dysuria, increase of bladder capacity and effective prevention of apparent microcyst. n 2 dwg, 2 tbl, 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702607-C1
priorityDate 2008-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452510107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452510108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3639

Total number of triples: 41.